Olympic 1500m champion Asbel Kiprop 'tested positive' for EPO

Image
AFP Paris
Last Updated : May 03 2018 | 10:05 AM IST

Former Olympic 1500 metres champion Asbel Kiprop vowed Wednesday to clear his name after reports he has tested positive for the endurance-boosting drug EPO.

Kenyan newspaper The Standard reported a high-profile athlete had failed a doping test, without naming Kiprop.

British newspaper the Guardian quoted Kiprop as saying: "As an athlete, I have been at the forefront of the fight against doping in Kenya, a fight I strongly believe in and support.

"I would not want to ruin all what I have worked for since my first international race in 2007. I hope I can prove that I am a clean athlete in every way possible." Kiprop's agent, Frederico Rosa, told the Guardian he had also heard the rumours but had no further information.

The sample is believed to have come from an out-of-competition test taken late in 2017.

It would be a serious blow to Kenyan athletics if it is confirmed that 28-year-old Kiprop, one of the biggest names in the country's stellar cast of middle-distance athletes, has tested positive for the endurance-enhancing drug erythropoietin (EPO).

Kiprop originally came second in the 1500m final at the 2008 Beijing Olympics but was upgraded when Rashid Ramzi tested positive for a performance-enhancing drug and was stripped of the gold medal.

Kenya has been fighting intense criticism of its anti-doping efforts after more than 40 athletes tested positive over the past five years. Three years ago, Kenya was rated "non-compliant" by the World Anti-Doping Agency (WADA) before being reinstated prior to the Rio Olympics.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 03 2018 | 10:05 AM IST

Next Story